Effects of trimethoprim and sulfisoxazole, alone and in combination, on growth and carriage of Neisseria meningitidis.
D002353:Carrier State / Q000188:drug therapy*; D004338:Drug Combinations; D004352:Drug Resistance, Microbial; D006801:Humans; D008589:Meningococcal Infections / Q000188:drug therapy*; D008826:Microbial Sensitivity Tests; D008887:Military Medicine; D009305:Nasopharynx / Q000382:microbiology; D009345:Neisseria meningitidis / Q000187:drug effects* / Q000302:isolation & purification; D013411:Sulfadiazine / Q000008:administration & dosage / Q000494:pharmacology; D013444:Sulfisoxazole / Q000008:administration & dosage* / Q000097:blood / Q000494:pharmacology; D013449:Sulfonamides / Q000494:pharmacology; D014295:Trimethoprim / Q000008:administration & dosage* / Q000097:blood / Q000494:pharmacology; D014481:United States
D004338:Drug Combinations; D013449:Sulfonamides; D013411:Sulfadiazine; D013444:Sulfisoxazole; D014295:Trimethoprim